Literature DB >> 11176863

Prospects for cardiovascular research.

R J Lefkowitz1, J T Willerson.   

Abstract

Cardiovascular disease is the greatest threat to human life and health. The past decade has seen remarkable progress in clinical and basic cardiovascular research, and many areas of opportunity are promising. The pace of current progress in clinical and basic research is such that remarkable improvement in the quality and length of life for those at risk for cardiovascular disease is likely.

Entities:  

Mesh：

Year:  2001        PMID： 11176863     DOI： 10.1001/jama.285.5.581

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


  22 in total

1.  Matters of the heart transcriptome: a brief history of cardiovascular genomics.

Authors:  Pilar M Labordé-Lahoz
Journal:  Tex Heart Inst J       Date:  2002

Review 2.  Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.

Authors:  Brahmajee K Nallamothu; A Mark Fendrick; Gilbert S Omenn
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 3.  Oxidative stress and atherosclerosis.

Authors:  P Christian Schulze; Richard T Lee
Journal:  Curr Atheroscler Rep       Date:  2005-05       Impact factor: 5.113

Review 4.  Molecular inflammation: underpinnings of aging and age-related diseases.

Authors:  Hae Young Chung; Matteo Cesari; Stephen Anton; Emanuele Marzetti; Silvia Giovannini; Arnold Young Seo; Christy Carter; Byung Pal Yu; Christiaan Leeuwenburgh
Journal:  Ageing Res Rev       Date:  2008-07-18       Impact factor: 10.895

Review 5.  Cell transplantation in non-ischemic dilated cardiomyopathy. A novel biological approach for ventricular restoration.

Authors:  Nobuhisa Ohno; Paul W M Fedak; Richard D Weisel; Masashi Komeda; Donald A G Mickle; Ren-Ke Li
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-11

6.  Different associations between blood pressure indices and carotid artery damages in a community-based population of China.

Authors:  G Cheng; F Fan; Y Zhang; L Qi; J Jia; Y Liu; L Gao; X Han; Y Yang; Y Huo
Journal:  J Hum Hypertens       Date:  2016-07-14       Impact factor: 3.012

7.  Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study.

Authors:  Tanja Rundek; Mitchell S Elkind; John Pittman; Bernadette Boden-Albala; Steve Martin; Steve E Humphries; Suh-Hang Hank Juo; Ralph L Sacco
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

8.  Traditional risk factors are not major contributors to the variance in carotid intima-media thickness.

Authors:  Tatjana Rundek; Susan H Blanton; Susanne Bartels; Chuanhui Dong; Ami Raval; Ryan T Demmer; Digna Cabral; Mitchell S V Elkind; Ralph L Sacco; Moise Desvarieux
Journal:  Stroke       Date:  2013-05-23       Impact factor: 7.914

9.  Human arteries engineered in vitro.

Authors:  J Andrew McKee; Soma S R Banik; Matthew J Boyer; Nesrin M Hamad; Jeffrey H Lawson; Laura E Niklason; Christopher M Counter
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

10.  Higher event rate in patients with known CAD despite a normal myocardial perfusion scan.

Authors:  Maseeh Uz Zaman; Nosheen Fatima; Unaiza Zaman; Areeba Zaman; Dad J Balcoh; S Zahed Rasheed
Journal:  Cardiovasc Diagn Ther       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.